Militia Capital Management Portfolio holdings
Militia Capital Management is an investment adviser owned entirely by David Orr that runs a global long/short equity strategy for a single client, the private fund Militia Capital Partners. Orr, founder and chief investment officer of the affiliated company Militia Investments, also manages the Militia Long/Short Equity ETF, which launched in January 2025. The private fund can also allocate its money among selected portfolio managers, each running a separate strategy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abivax
ABVX
|
+$14M |
| 2 |
Karman Holdings
KRMN
|
+$10.2M |
| 3 |
Regal Rexnord
RRX
|
+$8.75M |
| 4 |
SPDR Gold Trust
GLD
|
+$7.92M |
| 5 |
Bank of N.T. Butterfield & Son
NTB
|
+$7.85M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$14.1M |
| 2 |
Moderna
MRNA
|
+$8.58M |
| 3 |
Amazon
AMZN
|
+$6.35M |
| 4 |
iShares Biotechnology ETF
IBB
|
+$4.58M |
| 5 |
Novo Nordisk
NVO
|
+$4.39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 83.28% |
| 2 | Financials | 3.44% |
| 3 | Healthcare | 2.68% |
| 4 | Industrials | 2.63% |
| 5 | Technology | 2.15% |
Similar funds
Militia Capital Management's Q3 2026 Portfolio in Review
As of Q3 2026, Militia Capital Management held 385 positions worth $4B, up 19% from $3.37B the previous quarter. Its ten largest holdings account for 81% of the portfolio.
Militia Capital Management deployed $180M of net new capital in Q3 2026, opening 107 new positions and adding to 90 existing holdings. Its largest new stake was Abivax: 116,251 shares worth $11.5M.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, down from 84% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Moderna, an estimated $8.58M trimmed.
- Militia Capital Management's largest Q3 2026 buy was Abivax: 116,251 shares worth $11.5M.
- Militia Capital Management added most to Karman Holdings in Q3 2026, an estimated $10.2M increase.
- Militia Capital Management's biggest Q3 2026 reduction was Moderna, cutting an estimated $8.58M.
- Militia Capital Management fully exited TSMC in Q3 2026, selling an estimated $14.1M.
- Militia Capital Management's ten largest holdings make up 81% of its $4B portfolio in Q3 2026.
- Militia Capital Management opened 107 new positions and closed 71 in Q3 2026.
- Militia Capital Management's portfolio value rose 19% quarter-over-quarter to $4B.
Based on Militia Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.